Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.49 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.45 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.40 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.40 |
| ▸ | CXCR5 | P32302 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.40 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6252397 | 0.86 | PTGS2 (0.48) | GRM2PTGS2CLCN2ACMSDKDM4E | |
| SCHEMBL11580876 | 0.85 | CLCN2 (0.55) | GRM2PTGS2CLCN2ACMSDKDM4E | |
| SCHEMBL30657553 | 0.83 | PTGS2 (0.49) | GRM2PTGS2CLCN2ACMSDKDM4E | |
| SCHEMBL3076858 | 0.80 | CSF1R (0.48) | GRM2CLCN2ACMSDTSHRCSF1R | |
| SCHEMBL29200125 | 0.80 | CLCN2 (0.45) | GRM2PTGS2CLCN2ACMSDKDM4E | |
| SCHEMBL3076846 | 0.78 | PSMB5 (0.46) | GRM2CLCN2ACMSDHSD17B10ALDH1A1 | |
| SCHEMBL11815728 | 0.78 | PTGS2 (0.59) | GRM2PTGS2CLCN2ACMSDTSHR | |
| SCHEMBL188942 | 0.77 | PTGS2 (0.47) | GRM2PTGS2CLCN2ACMSDHSD17B10 | |
| SCHEMBL29216099 | 0.76 | CLCN2 (0.40) | GRM2PTGS2CLCN2ACMSDHSD17B10 | |
| SCHEMBL3092798 | 0.76 | CSF1R (0.41) | GRM2PTGS2ACMSDALDH1A1CXCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1807406-A2 | INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-07-18 | — | — | EP | claimed |
| WO-2006047503-A2 | INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA (BE) | 2006-05-04 | — | — | WO | claimed |
| US-20050113566-A1 | Inhibitors of C-FMS kinase | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-05-26 | — | — | US | claimed |
| EP-1807406-A2 | INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006047503-A2 | INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA (BE) | 2006-05-04 | — | — | WO | disclosed |
| US-20050113566-A1 | Inhibitors of C-FMS kinase | JANSSEN PHARMACEUTICA N.V. (BE) | 2005-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113566-A1 | Inhibitors of C-FMS kinase | ALK, TYRO3, PDGFRB | BCAT2 2408/4885GRM2 1758/4885PTGS2 2530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.